Cost-effectiveness of open versus laparoscopic pancreatectomy: A nationwide, population-based study

Jun Suh Lee; Ha Lynn Oh; Yoo-Seok Yoon; Ho-Seong Han; Jai Young Cho; Hae-Won Lee; Boram Lee; MeeYoung Kang; Yeshong Park; Jinju Kim

doi:10.1016/j.surg.2024.03.046

Cost-effectiveness of open versus laparoscopic pancreatectomy: A nationwide, population-based study

Surgery. 2024 May 20:S0039-6060(24)00212-5. doi: 10.1016/j.surg.2024.03.046. Online ahead of print.

Authors

Jun Suh Lee¹, Ha Lynn Oh², Yoo-Seok Yoon³, Ho-Seong Han⁴, Jai Young Cho⁴, Hae-Won Lee⁴, Boram Lee⁴, MeeYoung Kang⁴, Yeshong Park⁴, Jinju Kim⁴

Affiliations

¹ Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
² Health Insurance Policy Research Institute, National Health Insurance Service, Wonju, Gangwon-do, Republic of Korea.
³ Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: yoonys@snubh.org.
⁴ Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

PMID: 38772778
DOI: 10.1016/j.surg.2024.03.046

Abstract

Background: Laparoscopic pancreatic resection is comparable to open pancreatic resection; however, cost-effectiveness analyses of laparoscopic pancreatic resection are scarce. The authors performed a population-based study investigating the cost-effectiveness of laparoscopic pancreatic resection versus open pancreatic resection.

Methods: Data from 9,256 patients who received pancreaticoduodenectomy (66.8%) and distal pancreatectomy (33.2%) from 2016 to 2018 were retrieved from the Korean National Health Insurance Service. Events after pancreatectomy were categorized as no complication, complication, and death. Probabilities of each event and average cost during index admission and 1 year were utilized to calculate incremental cost-effectiveness ratio, the cost difference between two interventions divided by quality-adjusted life year. Quality-adjusted life year, a function of length and quality of life, was measured with utility values determined by researching literature.

Results: Laparoscopic pancreatic resection was performed in 12.4% of pancreaticoduodenectomies and 53.4% of distal pancreatectomies. For pancreaticoduodenectomy, laparoscopic pancreatic resection was associated with an increase of 0.0022 quality-adjusted life years for index admission and 0.0023 quality-adjusted life years for 1 year compared with open pancreatic resection. The incremental cost was $321 for index admission and -$1,414 for 1 year, leading to an incremental cost-effectiveness ratio of $147,429 per quality-adjusted life year gained for index admission and -$614,965 per quality-adjusted life year gained for 1 year. For distal pancreatectomy, laparoscopic pancreatic resection improved 0.0131 quality-adjusted life years for index admission and 0.0285 quality-adjusted life years for index admission. The incremental cost was -$1,240 for index admission and -$5,875 for 1 year, leading to an incremental cost-effectiveness ratio of -$94,519 per quality-adjusted life year gained for index admission and -$206,351 for 1 year.

Conclusion: laparoscopic pancreatic resection was a cost-effective alternative to open pancreatic resection for pancreaticoduodenectomy and distal pancreatectomy, except for the higher cost of index admission for pancreaticoduodenectomy.